Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Myc Proto Oncogene Protein - Pipeline Review, H1 2020
US$ 3,500.00
Myc Proto Oncogene Protein - Pipeline Review, H1 2020 SUMMARY Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) pipeline Target constitutes cl...
March 2020
55 pages
Neuropeptide Y Receptor Type 2 - Pipeline Review, H1 2020
US$ 3,500.00
Neuropeptide Y Receptor Type 2 - Pipeline Review, H1 2020 SUMMARY Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Neuropeptide Y receptor type 2 (Y2R) is a protein encoded by the NPY2R g...
March 2020
34 pages
Somatostatin Receptor Type 4 - Pipeline Review, H1 2020
US$ 3,500.00
Somatostatin Receptor Type 4 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Somatostatin Receptor Type 4 - Pipeline Review, H1 2020'; Somatostatin Receptor Type 4 (SS...
March 2020
38 pages
Kaposi Sarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Kaposi Sarcoma (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Kaposi Sarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
294 pages
Dyslipidemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Dyslipidemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dyslipidemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
372 pages
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2020
US$ 2,500.00
... The Human Immunodeficiency Virus (HIV) Infections (AIDS) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Human Immunodeficiency Virus (HIV) Infections (AIDS) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
1202 pages
Arrhythmias - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Arrhythmias (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arrhythmias and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
87 pages
Viral Conjunctivitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Viral Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
50 pages
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
558 pages
Alzheimer's Disease - Pipeline Review, H1 2020
US$ 2,500.00
... . The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
1716 pages
Atrial Fibrillation - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Atrial Fibrillation (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atrial Fibrillation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
127 pages
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
February 2020
178 pages
Diabetic Gastroparesis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diabetic Gastroparesis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Gastroparesis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
72 pages
Drug Addiction - Pipeline Review, H1 2020
US$ 2,000.00
... . The Drug Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Drug Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
221 pages
Duchenne Muscular Dystrophy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
381 pages
Epilepsy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
605 pages
Genital Herpes - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Genital Herpes (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Genital Herpes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
116 pages
Myocardial Ischemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
88 pages
Nasopharyngeal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Nasopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
688 pages
Oral Mucositis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Oral Mucositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
128 pages
Osteoarthritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
345 pages
Rectal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
202 pages
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Muscular Atrophy (SMA) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
February 2020
167 pages
Candidiasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Candidiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Candidiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
204 pages
Cough - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
112 pages
Diabetic Nephropathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diabetic Nephropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
264 pages
Ocular Hypertension - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
145 pages
African Trypanosomiasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The African Trypanosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for African Trypanosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
63 pages
Cat Allergy - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Cat Allergy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Cat Allergy (Immunology), complete with analysis by stage of development ...
February 2020
31 pages
Polycythemia Vera - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Polycythemia Vera (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Polycythemia Vera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
129 pages
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for B-Cell Chronic Lymphocytic Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
211 pages
Bronchopulmonary Dysplasia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bronchopulmonary Dysplasia (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchopulmonary Dysplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
76 pages
Burns - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Burns (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
108 pages
Osteosarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Osteosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Osteosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
726 pages
Pruritus - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
207 pages
Blepharitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Blepharitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
February 2020
61 pages
Encephalomyelitis - Pipeline Review, H1 2020
US$ 2,000.00
... . The Encephalomyelitis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
65 pages
Fabry Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Fabry Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fabry Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
February 2020
112 pages
